Botanical species · safety record

Mimusops elengi

The EFSA Compendium of Botanicals holds 8 constituent measurements for Mimusops elengi. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Mimusops elengi L.

8Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Gallic acid	Bark	Solvent extraction	—	Phytochemical screening	Resolve DOI
Pentacyclic triterpene saponins	Seed	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Pentacyclic triterpene saponins	Seed	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Bark	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Pentacyclic triterpene saponins	Seed	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Pentacyclic triterpene saponins	Flower	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Saponins	Bark	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Bark	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Sahu, NP. Triterpenoid saponins of Mimusops elengi. PHYTOCHEMISTRY, 1996, vol. 41, no. 3, p. 883-886. DOI
Katedeshmukh, R.G., Shete, R.V., Otari, K.V., Bagade, M.Y., Pattewar, A. Acute toxicity and diuretic activity of Mimusops elengi extracts. International Journal of Pharma and Bio Sciences, 2010, vol. 1, no. 3.
Sahu, Niranjan P., Koike, Kazuo., Jia, Zhonghua., Nikaido, Tamotsu. Minor triterpenoid saponin from Mimusops elengi. Natural Medicines, 1998, vol. 52, no. 1, p. 78-81.
SAHU, NP., KOIKE, K., JIA, ZH., NIKAIDO, T. NOVEL TRITERPENOID SAPONINS FROM MIMUSOPS ELENGI. Tetrahedron, 1995, vol. 51, no. 48, p. 13435-13446. DOI
Singh, Rajbir., Kachroo, Monika., Agrawal, Shyam S. Standardization of Centipeda minima, Mimusops elengi, Orchis mascula and Paeonia emodii. INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE, 2009, vol. 8, no. 3, p. 338-345.
Akhtar, Nida., Ali, Mohd., Alam, Mohd. Sarwar. Gallic acid esters from the stem bark of Mimusops elengi L.. NATURAL PRODUCT RESEARCH, 2010, vol. 24, no. 10, p. 962-972. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature